{"id":"placebo-for-sarpogrelate","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Placebo serves as a negative control in clinical trials to establish baseline efficacy and safety profiles against which the active drug (Sarpogrelate) is compared. It contains no active pharmaceutical ingredient and produces therapeutic effects only through psychological mechanisms (placebo effect). In this Phase 3 trial context, placebo allows researchers to isolate the true pharmacological effects of Sarpogrelate from non-specific patient responses.","oneSentence":"Placebo is an inert control substance with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:27:29.905Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in Phase 3 trial of Sarpogrelate (active comparator: Sarpogrelate for peripheral arterial disease or thrombotic conditions)"}]},"trialDetails":[{"nctId":"NCT02294643","phase":"PHASE3","title":"Study Design of 'Influence of Sarpogrelate in Patients With Renal Impairment or Diabetes Mellitus' Study","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2009-04","conditions":"Coronary Artery Disease, Diabetes Mellitus, Renal Insufficiency, Chronic","enrollment":220}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["sugar pill manufactured to mimic sarpogrelate tablet"],"phase":"phase_3","status":"active","brandName":"Placebo (for Sarpogrelate)","genericName":"Placebo (for Sarpogrelate)","companyName":"Seoul National University Bundang Hospital","companyId":"seoul-national-university-bundang-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo is an inert control substance with no active pharmacological mechanism. Used for Control arm in Phase 3 trial of Sarpogrelate (active comparator: Sarpogrelate for peripheral arterial disease or thrombotic conditions).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}